Cargando…
Drug-Induced Thrombotic Microangiopathy Resulting in ESRD
Autores principales: | Agarwal, Krishna A., Heher, Yael K., Denker, Bradley M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403540/ https://www.ncbi.nlm.nih.gov/pubmed/32775839 http://dx.doi.org/10.1016/j.ekir.2020.06.016 |
Ejemplares similares
-
Diagnostic Dilemma of Thrombotic Microangiopathy in Pregnancy
por: Kaartinen, Kati, et al.
Publicado: (2020) -
Treatment of Gemcitabine-Induced Thrombotic Microangiopathy Followed by Gemcitabine Rechallenge With Eculizumab
por: Efe, Orhan, et al.
Publicado: (2021) -
IgA-Dominant Glomerulopathy and Thrombotic Microangiopathy After Chemotherapy
por: Dvanajscak, Zeljko, et al.
Publicado: (2017) -
Kidney-Predominant Thrombotic Microangiopathy Associated With TREX1 Frameshift Mutation
por: Song, Zhuo-ran, et al.
Publicado: (2023) -
Interferon-β1a-Induced Thrombotic Microangiopathy: Possible Implication of the Alternative Pathway of the Complement
por: Taghavi, Maxime, et al.
Publicado: (2022)